Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....
SHANGHAI, April 10, 2025 /PRNewswire/ -- How does a childrenswear brand spark nostalgia for childhood across generations in the whole nation? How does a...
KUALA LUMPUR, Malaysia, April 10, 2025 /PRNewswire/ -- FaceAnne, a new skincare brand designed to meet the needs of the modern Malaysian consumer is...